Stephan A Mayer: Early Imaging Reveals Higher Risk of Hematoma Expansion After ICH
Stephan A Mayer, Neurointensivist, shared a post on X about a recent article by Jennifer A. Frontera et al., published in Neurocritical Care, adding:
”In this single center observational cohort study, ICH patients had a 20 percent risk of hematoma expansion overll.
In general the risk was greatest the earlier they were imaged, and was doubled among those on combination anticoagulation (i.e. DOAC, warfarin) and any form of antiplatelet therapy.
No other agent specific risks were uncovered.”
Title: Risk and Timing of Intracerebral Hemorrhage Expansion Among Patients Treated with Antithrombotic Agents
Authors: Jennifer A. Frontera, Joanna M. Marmo, Bavica Gummadi, Nicholas Mulchan, Harpaul S. Bhamra, Benjamin Brush, D. Ethan Kahn, Lindsey Kuohn, Sok Lee, Ariane Lewis, Melanie Li, Aaron Lord, Rajanandini Muralidharan, Nirmala Raghunath, Ting Zhou, Kara R. Melmed
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 13, 2026, 11:08Renel Tique: 5th International Conference on Hemophilia and Rare Bleeding Disorders
-
Oct 13, 2026, 02:01Nour Al-Mozain: Is It Really Anti-D? – Unraveling Auto-Anti-LW in the Transfusion Laboratory
-
Oct 13, 2026, 01:51Berenice Villegas: The Role of Morphologic Evaluation in Body Fluid Differential Analysis
-
Oct 13, 2026, 01:44Debadrita Ray: Evaluating vWF and VITRO Score for Detecting CSPH in cACLD Patients
-
Oct 13, 2026, 01:34Nagesh Ramesh: Donating Blood for International Plasma Awareness Week
-
Oct 12, 2026, 21:51Sam Botchey: Orthobiologics Are Advancing but the Evidence Must Keep Pace
-
Oct 12, 2026, 21:50Serum Vitamin D, Platelet Function, and Bleeding in Primary ITP – Platelets Journal
-
Oct 12, 2026, 21:30Nika Samadzadeh Tabrizi: Looking Forward to the PACeS Trial on Anticoagulation for POAF
-
Oct 12, 2026, 21:28Michael Megaly: Does Coronary Ectasia Affect Outcomes in Acute Coronary Syndromes?